LIGAND PHARMACEUTICALS INCORPORATED Financing Receivable, before Allowance for Credit Loss, Noncurrent
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Financing Receivable, before Allowance for Credit Loss, Noncurrent of $3.21 million as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net
us-gaap:NotesAndLoansReceivableGrossNoncurrent · last filed 2017-05-09
- 2017-03-31: Financing Receivable, before Allowance for Credit Loss, Noncurrent $3.21M.
- 2016-12-31: Financing Receivable, before Allowance for Credit Loss, Noncurrent $0.00.
| Period end | Financing Receivable, before Allowance for Credit Loss, Noncurrent |
|---|---|
| 2017-03-31 | $3.21M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $0.00 10-Q · filed 2017-05-09 |